arrow
A

Aniruddha Hazra

university of chicago
H指数:18
被引数:1,712

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The safety and tolerability of oral TDF/FTC as pre-exposure prophylaxis among men who have sex with men in China: a prospective cohort study

口服TDF/FTC作为暴露前预防在中国男男性行为者中的安全性和耐受性:一项前瞻性队列研究

2026-05-210
OAAI
Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis

多中心真实世界实施结果:Lenacapavir用于HIV暴露前预防

2026-05-150
PRE
The longitudinal effect of repetition and practice on the accuracy of lay anal examinations for detecting perianal and anal canal abnormalities: a prospective study

重复和练习对直肠指检准确性(用于检测肛周和肛管异常)的纵向影响:一项前瞻性研究

2025-12-060
OAAI
A community network-driven COVID-19 testing and vaccination intervention for vulnerable populations in the Central United States: results from a Rapid Acceleration of Diagnostics Underserved Populations randomized controlled trial

一项由社区网络驱动的针对美国中部弱势群体的COVID-19检测和疫苗接种干预措施:来自“未服务人群诊断加速”随机对照试验的结果

2025-11-030
PRE
Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic

在城市学术性艾滋病诊所中,长效注射用卡博格韦-利匹韦林启动的资格及关联因素

2025-09-010
PRE
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process

建立长效注射用卡博格韦和 rilpivirine 治疗的病毒学失败和停药共享定义(CONSENSUS-LAI 研究):一项国际调查和德尔菲过程

2025-08-040
OAAI
Preferences for Pre-Exposure Prophylaxis Implementation and Engagement in the HIV Pre-Exposure Prophylaxis Care Continuum Among Patients Receiving Psychiatric Care in an Ending the HIV Epidemic Priority County

在接受精神科治疗的“终结艾滋病流行”重点县患者中,对暴露前预防实施和参与艾滋病暴露前预防护理连续谱的偏好

2025-08-010
PRE
Early Virologic Success on Antiretroviral Therapy Among Individuals With Breakthrough HIV Acquisition on Long-Acting Cabotegravir Pre-exposure Prophylaxis

长效卡博格韦尔暴露前预防中突破性HIV感染者接受抗逆转录病毒治疗的早期病毒学成功

2025-06-010
OAAI